In this regard, circulating (or peripheral) blood cells from RA patients have been used in previous studies to assess the OPG/RANKL/TRAIL gene expression for prognosis or diagnosis of RA14, 15. This evidence concerns the gene TNFSF10 and rheumatoid arthritis.